Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03300336 · ClinicalTrials.gov registry record · NA

Optimizing Function and Independence Through STRIDE

A NA study, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
13,857
Enrollment target

NCT03300336: Completed NA study, sponsored by VA Office of Research and Development.

NCT03300336 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 13,857 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (888% higher). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03300336, a NA study, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
13,857 participants
Enrollment target

Study Summary

Optimizing Function and Independence Through STRIDE aims to implement the STRIDE inpatient hospital mobility program at 8 VAMC sites in a stepped-wedge design and evaluate patient outcomes before and after the program is implemented, as well as the efficacy of a usual vs enhanced implementation design.

Primary Outcome

Discharge to skilled nursing facility (versus home) will be assessed via administrative data pulls and chart review (not patient report).

Interventions

  • BEHAVIORAL STRIDE

Trial Details

FieldValue
Enrollment Target 13,857 participants
Start Date 2017-10-05
Est. Completion 2021-10-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT03300336 record still lists

NCT03300336 is an interventional study that assigns participants to a tested intervention. Its 13,857 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (888% higher).

The record links to 0 conditions, and to 1 intervention - of which STRIDE is the first listed.

NCT03300336 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03300336 about?

NCT03300336 is a clinical study titled "Optimizing Function and Independence Through STRIDE". Optimizing Function and Independence Through STRIDE aims to implement the STRIDE inpatient hospital mobility program at 8 VAMC sites in a stepped-wedge design and evaluate patient outcomes before and after the program is implemented, as well as the efficacy of a usual vs enhanced implementation desi...

What is the current status of trial NCT03300336?

This trial is currently completed. It is a NA study. The enrollment target is 13,857 participants. The study started on 2017-10-05. Estimated completion is 2021-10-30.

What interventions are being tested in trial NCT03300336?

The interventions under investigation include: STRIDE (BEHAVIORAL).

Who is sponsoring clinical trial NCT03300336?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03300336's enrollment target sits among peer trials

13,857 13th of 2000 higher than 1,988 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06058767 · 13,764 participants · NA

    Preschool Hearing Screening

  • NCT05141396 · 13,400 participants · NA

    Telehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)

  • NCT05591066 · 14,400 participants · NA

    The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now

  • NCT05359016 · 14,600 participants · NA

    Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03300336, the US trial registry maintained by the National Library of Medicine. NCT03300336 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.